Dabrafenib/trametinib/pembrolizumab

Autoimmune colitis, fatigue and nausea: 2 case reports

    Reactions Weekly volume 1838, page173(2021)Cite this article

    This is a preview of subscription content, access via your institution.

    Access options

    Buy single article

    Instant access to the full article PDF.

    US$ 49.95

    Tax calculation will be finalised during checkout.

    Reference

    1. Malkhasyan KA, et al. The clinical characteristics of melanoma with BRAF V600R mutation: a case series study. Melanoma Research 30: 107-112, No. 1, Feb 2020. Available from: URL: http://doi.org/10.1097/CMR.0000000000000630

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Dabrafenib/trametinib/pembrolizumab. Reactions Weekly 1838, 173 (2021). https://doi.org/10.1007/s40278-021-89492-y

    Download citation